For the 1.25 million Americans with type 1 diabetes (T1D), being able to choose and afford the tools they need to control their disease is critical to survival.
T1D is a costly disease – people with T1D incur almost three times the level of medical expenses compared to people without diabetes.
T1D is fatal without insulin; even if you can’t afford it, you cannot just stop taking insulin.
JDRF advocates passionately believe that giving people with diabetes control over their choices and their healthcare costs is not only the right thing to do, it’s also the smart thing.
Last week, our advocates met with Senator Rick Scott (pictured here, along with several JDRF advocates and current and former Children’s Congress delegates) announced the Transparent Drug Pricing Act, which promotes transparency in drug pricing and reduces the cost of prescription drugs for American consumers. Thank you for all of your hard work in advocating for policies that help families living with T1D!
Quality, affordable coverage helps people with T1D avoid costly emergency room visits, inpatient admissions, and other complications such as kidney failure, heart attacks, and strokes. Moreover, making it easier for people with chronic conditions like T1D to manage their disease is better for the economy because it keeps them healthy and productive, and reduces overall healthcare costs.
We’re pleased that making insulin more affordable is a priority in Washington. We look forward to working with Congress and the Administration in the days and months ahead to ensure those with T1D have access to affordable insulin.